Loading...

Ida Franiak-pietryga

Title(s)SRA 1, Radiation Medicine and Applied Science
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. There and back again: a dendrimer's tale. Drug Chem Toxicol. 2021 Apr 28; 1-16. Ziemba B, Borowiec M, Franiak-Pietryga I. PMID: 33910437.
      View in: PubMed   Mentions:    Fields:    
    2. All That Glitters Is Not Silver-A New Look at Microbiological and Medical Applications of Silver Nanoparticles. Int J Mol Sci. 2021 Jan 16; 22(2). Kowalczyk P, Szymczak M, Maciejewska M, Laskowski L, Laskowska M, Ostaszewski R, Skiba G, Franiak-Pietryga I. PMID: 33467032.
      View in: PubMed   Mentions:    Fields:    
    3. Neurotoxicity of poly(propylene imine) glycodendrimers. Drug Chem Toxicol. 2020 Nov 13; 1-9. Franiak-Pietryga I, Ziemba B, Sikorska H, Jander M, Appelhans D, Bryszewska M, Borowiec M. PMID: 33187456.
      View in: PubMed   Mentions:    Fields:    
    4. Maltotriose-modified poly(propylene imine) Glycodendrimers as a potential novel platform in the treatment of chronic lymphocytic Leukemia. A proof-of-concept pilot study in the animal model of CLL. Toxicol Appl Pharmacol. 2020 09 15; 403:115139. Franiak-Pietryga I, Ziemba B, Sikorska H, Jander M, Kuncman W, Danilewicz M, Appelhans D, Lewkowicz P, Ostrowska K, Bryszewska M, Borowiec M. PMID: 32687837.
      View in: PubMed   Mentions:    Fields:    
    5. B Cells Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Activated by Radiation and PD-1 Blockade. Clin Cancer Res. 2020 07 01; 26(13):3345-3359. Kim SS, Shen S, Miyauchi S, Sanders PD, Franiak-Pietryga I, Mell L, Gutkind JS, Cohen EEW, Califano JA, Sharabi AB. PMID: 32193227.
      View in: PubMed   Mentions: 4     Fields:    
    6. Anti-Tumour Activity of Glycodendrimer Nanoparticles in a Subcutaneous MEC-1 Xenograft Model of Human Chronic Lymphocytic Leukemia. Anticancer Agents Med Chem. 2020; 20(3):325-334. Ziemba B, Sikorska H, Jander M, Kuncman W, Danilewicz M, Appelhans D, Bryszewska M, Borowiec M, Franiak-Pietryga I. PMID: 31738155.
      View in: PubMed   Mentions:    Fields:    
    7. Affecting NF-κB cell signaling pathway in chronic lymphocytic leukemia by dendrimers-based nanoparticles. Toxicol Appl Pharmacol. 2018 10 15; 357:33-38. Franiak-Pietryga I, Ostrowska K, Maciejewski H, Ziemba B, Appelhans D, Voit B, Jander M, Trelinski J, Bryszewska M, Borowiec M. PMID: 30125597.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    8. Blockage of Wnt/ß-Catenin Signaling by Nanoparticles Reduces Survival and Proliferation of CLL Cells In Vitro-Preliminary Study. Macromol Biosci. 2017 11; 17(11). Franiak-Pietryga I, Maciejewski H, Ziemba B, Appelhans D, Voit B, Robak T, Jander M, Trelinski J, Bryszewska M, Borowiec M. PMID: 28762636.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    9. Glycodendrimer PPI as a Potential Drug in Chronic Lymphocytic Leukaemia. The Influence of Glycodendrimer on Apoptosis in In Vitro B-CLL Cells Defined by Microarrays. Anticancer Agents Med Chem. 2017; 17(1):102-114. Franiak-Pietryga I, Ziólkowska E, Ziemba B, Appelhans D, Maciejewski H, Voit B, Kaczmarek A, Robak T, Klajnert-Maculewicz B, Cebula-Obrzut B, Smolewski P, Borowiec M, Bryszewska M. PMID: 27349446.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    10. PPI-G4 Glycodendrimers Upregulate TRAIL-Induced Apoptosis in Chronic Lymphocytic Leukemia Cells. Macromol Biosci. 2017 05; 17(5). Franiak-Pietryga I, Ostrowska K, Maciejewski H, Appelhans D, Misiewicz M, Ziemba B, Bednarek M, Bryszewska M, Borowiec M. PMID: 27996200.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    11. Dendrimer-based nanoparticles for potential personalized therapy in chronic lymphocytic leukemia: Targeting the BCR-signaling pathway. Int J Biol Macromol. 2016 Jul; 88:156-61. Franiak-Pietryga I, Maciejewski H, Ostrowska K, Appelhans D, Voit B, Misiewicz M, Kowalczyk P, Bryszewska M, Borowiec M. PMID: 26987432.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    12. Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancer. Int J Pharm. 2014 Jan 30; 461(1-2):391-402. Ziemba B, Franiak-Pietryga I, Pion M, Appelhans D, Muñoz-Fernández MÁ, Voit B, Bryszewska M, Klajnert-Maculewicz B. PMID: 24361266.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    13. The influence of maltotriose-modified poly(propylene imine) dendrimers on the chronic lymphocytic leukemia cells in vitro: dense shell G4 PPI. Mol Pharm. 2013 Jun 03; 10(6):2490-501. Franiak-Pietryga I, Ziólkowska E, Ziemba B, Appelhans D, Voit B, Szewczyk M, Góra-Tybor J, Robak T, Klajnert B, Bryszewska M. PMID: 23641871.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    14. Toward personalized therapy for chronic lymphocytic leukemia: DSC and cDNA microarray assessment of two cases. . 2013 Jan; 14(1):6-12. Rogalinska M, Franiak-Pietryga I, Blonski JZ, Góralski P, Maciejewski H, Janus A, Robak P, Mirowski M, Piekarski H, Robak T, Kilianska ZM. PMID: 23114648.
      View in: PubMed   Mentions:
    15. Type of serum influences the rituximab dependent cytotoxicity and apoptosis of chronic lymphocytic leukemia cells in vitro. Postepy Hig Med Dosw (Online). 2012 Oct 22; 66:730-8. Ziólkowska E, Franiak-Pietryga I, Cebula-Obrzut B, Blonsk JZ, Robak T, Smolewski P, Korycka-Wolowiec A. PMID: 23175327.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    16. Changes in the apoptotic gene expression profile in CLL patients treated with rituximab combined with cladribine and cyclophosphamide-preliminary results. Leuk Res. 2012 Sep; 36(9):1134-40. Franiak-Pietryga I, Maciejewski H, Wolowiec D, Salagacka A, Blonski JZ, Janus A, Kotkowska A, Wawrzyniak E, Ghia P, Mirowski M, Robak T, Korycka-Wolowiec A. PMID: 22608309.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    17. Apoptotic gene expression under influence of fludarabine and cladribine in chronic lymphocytic leukemia-microarray study. Pharmacol Rep. 2012; 64(2):412-20. Franiak-Pietryga I, Salagacka A, Maciejewski H, Blonski JZ, Borowiec M, Mirowski M, Robak T, Korycka-Wolowiec A. PMID: 22661193.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    Ida's Networks
    Concepts (81)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (6)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑